155 related articles for article (PubMed ID: 30479618)
41. Single line source with and without vaginal loading and the impact on target coverage and organ at risk doses for cervix cancer Stages IB, II, and IIIB: treatment planning simulation in patients treated with MRI-guided adaptive brachytherapy in a multicentre study (EMBRACE).
Nkiwane KS; Pötter R; Tanderup K; Federico M; Lindegaard JC; Kirisits C
Brachytherapy; 2013; 12(4):317-23. PubMed ID: 23474352
[TBL] [Abstract][Full Text] [Related]
42. Point A vs. HR-CTV D
Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
[TBL] [Abstract][Full Text] [Related]
43. Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with
Safigholi H; Han DY; Mashouf S; Soliman A; Meigooni AS; Owrangi A; Song WY
Med Phys; 2017 Dec; 44(12):6538-6547. PubMed ID: 28940520
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of offline adaptive planning techniques in image-guided brachytherapy of cervical cancer.
Liu H; Kinard J; Maurer J; Shang Q; Vanderstraeten C; Hayes L; Sintay B; Wiant D
J Appl Clin Med Phys; 2018 Nov; 19(6):316-322. PubMed ID: 30284370
[TBL] [Abstract][Full Text] [Related]
45. Single Application Multifractionated Image Guided Adaptive High-Dose-Rate Brachytherapy for Cervical Cancer: Dosimetric and Clinical Outcomes.
Mahantshetty U; Gurram L; Bushra S; Ghadi Y; Aravindakshan D; Paul J; Hande V; Pilar A; Chopra S; Ghosh J; Shylasree TS; Popat P; Sable N; Maheswari A; Gupta S
Int J Radiat Oncol Biol Phys; 2021 Nov; 111(3):826-834. PubMed ID: 34146636
[TBL] [Abstract][Full Text] [Related]
46. Dosimetric consequences of interobserver variability in delineating the organs at risk in gynecologic interstitial brachytherapy.
Damato AL; Townamchai K; Albert M; Bair RJ; Cormack RA; Jang J; Kovacs A; Lee LJ; Mak KS; Mirabeau-Beale KL; Mouw KW; Phillips JG; Pretz JL; Russo AL; Lewis JH; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):674-81. PubMed ID: 24803035
[TBL] [Abstract][Full Text] [Related]
47. Dosimetric impact of interfraction catheter movement and organ motion on MRI/CT guided HDR interstitial brachytherapy for gynecologic cancer.
Rey F; Chang C; Mesina C; Dixit N; Kevin Teo BK; Lin LL
Radiother Oncol; 2013 Apr; 107(1):112-6. PubMed ID: 23333023
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of dosimetric impact of inter-application and intra-application variations in fractionated high-dose-rate intra-cavitary brachytherapy of cervical cancer.
Pasha T; Hassan HN; Radhakrishna N; N MS; Varghese AS; Viswanath L; Valuvil NB; S S; H B G; Khaleel I; Palled SR; Thimmaiah N
J Contemp Brachytherapy; 2021 Dec; 13(6):627-632. PubMed ID: 35079248
[TBL] [Abstract][Full Text] [Related]
49. [Historical overview and the current practice of intracavitary treatment of cervical and endometrial cancer in the Oncoradiology Center of Budapest].
Sinkó D; Nemeskéri C; Pallinger Á; Weisz C; Naszály A; Landherr L
Magy Onkol; 2015 Jun; 59(2):140-7. PubMed ID: 26035162
[TBL] [Abstract][Full Text] [Related]
50. A dosimetric comparison of Volumetric Modulated Arc Therapy (VMAT) and High Dose Rate (HDR) brachytherapy in localized cervical cancer radiotherapy.
Wali L; Helal A; Darwesh R; Attar M
J Xray Sci Technol; 2019; 27(3):473-483. PubMed ID: 30958322
[TBL] [Abstract][Full Text] [Related]
51. Incorporating Routine Magnetic Resonance Imaging-based Planning for the Delivery of High-dose-rate Brachytherapy for Prostate Cancer: An Evaluation of Clinical Feasibility and Dosimetric Outcomes.
Saigal K; All S; Potrebko P; Feranec N; Keller A; Lizaso M; Warner C; Nguyen N; Jain A; Biagioli M
Cureus; 2019 Feb; 11(2):e4085. PubMed ID: 31019863
[TBL] [Abstract][Full Text] [Related]
52. Characterizing the impact of adaptive planning on image-guided perineal interstitial brachytherapy for gynecologic malignancies.
Gladwish A; Ravi A; Barbera L; Mendez L; Davidson M; D'Alimonte L; D'Souza D; Wronski M; Leung E
Brachytherapy; 2018; 17(2):352-359. PubMed ID: 29241705
[TBL] [Abstract][Full Text] [Related]
53. A Prospective Comparison of Computed Tomography with Transrectal Ultrasonography Assistance and Magnetic Resonance Imaging-Based Target-Volume Definition During Image Guided Adaptive Brachytherapy for Cervical Cancers.
Mahantshetty U; Naga Ch P; Khadanga CR; Gudi S; Chopra S; Gurram L; Jamema S; Ghadi Y; Shrivastava S
Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1448-1456. PubMed ID: 30146092
[TBL] [Abstract][Full Text] [Related]
54. Reporting and validation of gynaecological Groupe Euopeen de Curietherapie European Society for Therapeutic Radiology and Oncology (ESTRO) brachytherapy recommendations for MR image-based dose volume parameters and clinical outcome with high dose-rate brachytherapy in cervical cancers: a single-institution initial experience.
Mahantshetty U; Swamidas J; Khanna N; Engineer R; Merchant NH; Deshpande DD; Shrivastava S
Int J Gynecol Cancer; 2011 Aug; 21(6):1110-6. PubMed ID: 21633296
[TBL] [Abstract][Full Text] [Related]
55. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
56. Novel use of ViewRay MRI guidance for high-dose-rate brachytherapy in the treatment of cervical cancer.
Ko HC; Huang JY; Miller JR; Das RK; Wallace CR; De Costa AA; Francis DM; Straub MR; Anderson BM; Bradley KA
Brachytherapy; 2018; 17(4):680-688. PubMed ID: 29773331
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of an MR-only interstitial gynecologic brachytherapy workflow using MR-line marker for catheter reconstruction.
Shaaer A; Paudel M; Smith M; Tonolete F; Nicolae A; Leung E; Ravi A
Brachytherapy; 2020; 19(5):642-650. PubMed ID: 32712027
[TBL] [Abstract][Full Text] [Related]
58. Interfraction Variations in Organ Filling and Their Impact on Dosimetry in CT Image Based HDR Intracavitary Brachytherapy.
Rangarajan R
J Med Phys; 2018; 43(1):23-27. PubMed ID: 29628630
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of interfractional variation of organs and displacement of catheters during high-dose-rate interstitial brachytherapy for gynecologic malignancies.
Lee S; Rodney E; Traughber B; Biswas T; Colussi V; Podder T
Brachytherapy; 2017; 16(6):1192-1198. PubMed ID: 28993108
[TBL] [Abstract][Full Text] [Related]
60. MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong.
Wu PY; Wong TPW; Yip YYC; Chang TYA; Chan LKL; Lee MCH; Law LYA; Yeung MWR; Soong SI
Brachytherapy; 2019; 18(2):171-179. PubMed ID: 30581053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
